www.rdworldonline.com
2026-06-24
NVIDIA's announcement of the BioNeMo agent toolkit represents a significant advancement in AI application within the biopharmaceutical sector. The platform has garnered support from nearly 50 major partners including Eli Lilly, Thermo Fisher, and Dassault Systèmes, demonstrating strong industry adop